US Stock MarketDetailed Quotes

CTMX CytomX

Watchlist
  • 1.080
  • +0.020+1.88%
Trading Dec 19 13:22 ET
84.51MMarket Cap6.75P/E (TTM)

CytomX Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

CytomX Q3 2024 Earnings Date

Currency：USDNov 7, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
17.10M
33.43M
+16.33M
Beat Est.
-35.19%
+26.71%
+95.51%
EPS
-0.16
0.07
+0.23
Beat Est.
-493.00%
+75.00%
+144.53%
Analyst Rating
Buy

Nov 30, 2024

CytomX Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 3 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 18.500M--
--2024/Q4-- / 13.533M--
Nov 7, 20242024/Q333.432M / 17.100M--
Aug 8, 20242024/Q225.115M / 19.994M--
May 8, 20242024/Q141.463M / 21.721M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 18.500M--
--2024/Q4-- / 13.533M--
Nov 7, 20242024/Q333.432M / 17.100M--
Aug 8, 20242024/Q225.115M / 19.994M--
May 8, 20242024/Q141.463M / 21.721M--

Unlock Free Earnings Estimates

CytomX Earnings Reports

  • CytomX | 8-K: CytomX Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update

    Nov 7 16:14 ET

  • CytomX | 10-Q: Q3 2024 Earnings Report

    Nov 7 16:03 ET

  • CytomX | 10-Q: Q2 2024 Earnings Report

    Aug 8 16:50 ET

  • CytomX | 8-K: CytomX Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Update

    Aug 8 16:15 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Nov 30, 2024

    Buy

    • Buy

      66.67%

    • Hold

      33.33%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Price
    % Chg

    No Data